Albarico, Anunciacion A.
HRN: 00-51-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/25/2022
05/01/2022
IV
600 Mg
Q8hrs
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes